Digitalcontinuity.solutions

What Digitalcontinuity.solutions does

Digitalcontinuity.solutions (operating under the short name 'digico') is a Brussels-headquartered, privately held technology company founded in 2019 that develops low-code software for pharmaceutical and life sciences regulatory workflows. The company offers two core products: Active Content, which surfaces document content directly into regulatory processes and includes AI-enabled document tagging; and Active Supply, which supports supply and production planning by addressing regulatory hurdles. The platform integrates top quadrant solutions with low-code features to deliver automation and consistency for regulated environments.

The company operates with a lean team of approximately 5 employees and a four-person C-suite (CEO Thierry Pirlot, CFO François Morucci, CSO Sophie Weyh, COO Jean-Nicolas Lempereur), and presents itself as a bootstrapped, founder-led startup. Its stated customer base spans global enterprises in pharmaceuticals (GSK, Viatris), government (European Commission), and financial services (SGG), though no customer concentration, revenue, or contract details are disclosed.

Digitalcontinuity.solutions monetizes through subscription or enterprise software licensing on a quote-based model with no public pricing, distributing directly via enterprise field sales to pharma and life sciences buyers worldwide. Marketing is primarily conducted through its Squarespace-hosted website and a newsletter subscription funnel, with direct email contact ([email protected]) and a French phone number (+33 6 10 69 65 82) for sales engagement.

Name

Digitalcontinuity.solutions

Legal name

Digitalcontinuity.solutions

Website

https://digitalcontinuity.solutions

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Digitalcontinuity.solutions (digico) is a Brussels-based, bootstrapped low-code software startup founded in 2019 that builds Active Content and Active Supply to streamline pharmaceutical regulatory document workflows and supply planning for global enterprise clients including GSK and Viatris.

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Software

NAICS

Software Publishers (5132), Computer Systems Design Services (541512)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Industry-Specific Low-Code Platforms (Vertical App Platforms) (HDAEAKAL)

akta.pro secondary industries

Process & Case Management Low-Code Platforms (HDAEAKAE), Document, Workflow & Policy Servicing Automation (RPA/No-Code) (FSAGAGAK)

Keywords

• Pharmaceutical regulatory software
• Life sciences compliance
• Low-code development platform
• Regulatory document automation
• Pharma supply planning

Headquarters

HQ city

Not specified

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Software Licensing/Subscription: The company offers software solutions (Active Content, Active Supply) as products for pharmaceutical regulatory compliance and process optimization. Based on the B2B enterprise model and customer references, revenue is generated through software licensing or subscription fees for their regulatory technology solutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Digitalcontinuity.solutions (digico) develops low-code enterprise software for the life sciences industry. Its flagship product, Active Content, uses AI to automate tagging and management of regulatory submission documents for pharmaceutical companies. Its second product, Active Supply, provides production and supply chain planning for pharmaceutical manufacturers. Together the two products address both regulatory documentation and supply planning workflows on a single low-code platform.

Product overview

Digitalcontinuity.solutions (digico) is a tech startup focusing on Life Sciences, developing, implementing and integrating solutions to support the pharmaceutical industry to meet regulatory needs and improve and streamline business processes. The company offers a platform of two core products: Active Content and Active Supply. Active Content handles document surfacing and AI-powered document tagging for regulatory processes, while Active Supply focuses on supply and production planning to overcome regulatory hurdles. The company positions itself as integrating top quadrant solutions with smart and low-code features to create automation and consistency for global pharmaceutical clients.

Differentiator

Problem solved

Functional benefit

Brands

• Active Content: Surfacing document content right into regulatory processes.
• Active Supply

Products and services

• Active Content AI-powered document tagging and management platform for pharmaceutical regulatory submissions, automating classification and organization of regulatory dossiers for pharma manufacturers and regulatory affairs teams.
• Active Supply Production and supply planning software for pharmaceutical manufacturers, enabling coordinated production scheduling and supply chain visibility across life sciences operations.

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Appian: Appian is a low-code process automation platform widely deployed in regulated industries including life sciences for case management, document processing, and compliance workflows. It is comparable as a broad incumbent offering low-code process automation that could substitute for some of Digitalcontinuity.solutions' positioning.
• Veeva Systems: Veeva is the dominant cloud software provider for the life sciences industry, with a deep suite of regulatory, quality, clinical, and commercial solutions. It is highly comparable as a broad incumbent serving the same pharma regulatory buyer with overlapping capabilities (regulatory information management, document management), though it is vastly larger and far more comprehensive than Digitalcontinuity.solutions.
• IQVIA: IQVIA is a global life sciences technology and services giant offering regulatory technology, clinical trial, and commercial analytics solutions. It is a broad incumbent with adjacent regulatory and document automation offerings, comparable in serving the same pharma enterprise buyer but operating at vastly greater scale.
• Pega (Pegasystems): Pega provides a low-code process automation platform used across regulated industries including pharma for case management and workflow automation. It is a broad incumbent whose low-code platform approach overlaps conceptually with Digitalcontinuity.solutions' low-code positioning, though Pega is horizontal rather than pharma-specific.

Emerging players

• Dot Compliance: Dot Compliance offers AI-driven quality management and compliance solutions for life sciences. It is an emerging player with comparable vertical specialization and AI-based document/compliance automation, though its current focus is more on QMS than submission RIM specifically.

Direct peers

• ArisGlobal: ArisGlobal provides LifeSphere regulatory, safety, and clinical software to pharma and biotech companies. It is a direct peer competing for the same regulatory affairs buyer with overlapping RIM and submission management capabilities, and is more closely matched in company size and product focus than the broad incumbents.
• EXTEDO: EXTEDO specializes in regulatory information management (RIM) and submission publishing software for life sciences, including submission planning, document management, and health authority interaction tools. It is one of the most directly comparable peers in pharma regulatory document workflows and submission automation.
• Instem (Instem Life Sciences): Instem provides software and services for life sciences R&D, including regulatory-driven submission and document workflows across preclinical and clinical. It is a direct peer in life sciences regulatory document technology, with comparable company size and vertical focus.
• Lionbridge (Amplexor Life Sciences): Lionbridge (formerly Amplexor) provides regulatory information management and life sciences content solutions including submission management and multilingual regulatory content. It is a direct peer in pharma RIM and regulatory document workflows, comparable in target buyer and product scope.
• Generis (CARA Life Sciences Platform): Generis provides the CARA platform for regulatory information management, content management, and pharmacovigilance across life sciences. It is a direct peer serving the same regulatory buyer with overlapping RIM and document workflow capabilities, and often competes head-to-head with ArisGlobal and EXTEDO.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/digitalcontinuity-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digitalcontinuity.solutions